Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBP for ischemic cerebrovascular disease with cognitive impairment
ChiCTR-TRC-09000440Phase 4Completed
- Sponsor
- Xuanwu Hospital
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of butylphthalide in Ischaemic cerebral disease (2 arms), sponsored by Xuanwu Hospital. Primary endpoints: ECG, Clinical examination and 5 more. Started Mar 2008; status: completed.
02
Drugs
butylphthalide
03
Conditions
Ischaemic cerebral disease
Beyond the preview
Go deeper on ChiCTR-TRC-09000440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000440.